CXCL13 and opsoclonus-myoclonus syndrome: Our research on CSF in pediatric OMS has shown that B cells are expanded [2], B cell chemoattractant CXCL13 [3] and B/T cell chemoattractant CXCL10 [4] are likewise overexpressed, and 35% of the patients harbor oligoclonal bands.